
Systems Analytics Inc (AKA: Seven Pebbles Corporation) Profile last edited on: 11/12/13
CAGE: 35GF1
UEI:
Business Identifier: Biomarker discovery and evaluation Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
946 Great Plain Avenue Suite 125
Needham, MA 02492
Needham, MA 02492
(781) 444-4837 |
info@systemsanalytics.com |
www.systemsanalytics.com |
Location: Single
Congr. District: 04
County: Norfolk
Congr. District: 04
County: Norfolk
Public Profile
Formerly known as Seven Pebbles, Systems Analytics is a bioinformatics company serving government, pharmaceutical and biotechnology industry and academic research institutions for the discovery and evaluation of biomarkers of clinical and scientific significance. The firm specializse in state-of-the-science data mining, pattern recognition, and uncertainty analysis computational algorithms for the analysis of high throughput biological data such as genomics, proteomics, metabolic profiling, and their integration in a Systems Biology approach. The firm provide computational support to biologists in the elucidation of the molecular mechanisms of various pathological conditions including cancer and to facilitate the identification of novel biomarkers with potential in early diagnosis, prognosis, treatment response, and management of human diseases. Systems Analyticsâ bioinformatics capabilities that performs integrated analysis with genomics, proteomics, and metabolomics data profiles obtained from sources such as blood/plasma, urine, biopsy/tissue, spinal fluid, etc, and provides needed information to users from a large variation of applications in a systems biology approach. Systems Analyticsâ mission is to discover biomarkers of clinical and scientific significance by developing, improving and applying genomics, proteomics, metabolomics, and bioinformatics technologies. The objective of the discovery will focus on biomarkers for the early detection, treatment, and management of disease and toxicological effects upon external and internal impact, and on the understanding of the biological mechanism
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2009 | 1 | OSD | $99,928 | |
Project Title: Getting the Word Out | ||||
2009 | 1 | DARPA | $98,995 | |
Project Title: Mathematical Modeling of Dynamic Social Networks | ||||
2007 | 1 | OSD | $99,965 | |
Project Title: Software Technology for Cancer Epidemiology and Prevention | ||||
2006 | 2 | AF | $849,284 | |
Project Title: Bioinformatics Software for Proteomics Research | ||||
2005 | 1 | NSF | $99,987 | |
Project Title: A Proteomic-Based Biometric System for Near-Real Time Detection of Less-Than-Lethal Exposures to CBRN Materials |
Key People / Management
John Zhang -- President
Elizabeth Newton
Elizabeth Newton